63323-132 : Mitoxantrone 2 mg/ml Intravenous Injection, Solution


NDC63323-132
Labeler: App Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Mitoxantrone
Dosage Form: Intravenous Injection, Solution
Application #: ANDA077496
Rev. Date: 


NDC Package Codes:

  • 63323-132-10: 1 VIAL, MULTI‑DOSE IN 1 BOX (63323‑132‑10) > 10 ML IN 1 VIAL, MULTI‑DOSE
  • 63323-132-12: 1 VIAL IN 1 BOX (63323‑132‑12) > 12.5 ML IN 1 VIAL
  • 63323-132-15: 1 VIAL, MULTI‑DOSE IN 1 BOX (63323‑132‑15) > 15 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Mitoxantrone Hydrochloride

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0703-4680 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4685 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4686 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 55390-083 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-084 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-085 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 61703-343 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Hospira Worldwide, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63323-132 QR Code

< Prev: 63323-130Next: 63323-136 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA